Human blood platelet serotonin studiedin vitro: endogenous serotonin may stimulate thrombin-induced serotonin release in stored platelets
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 7 (1-2) , 53-57
- https://doi.org/10.3109/09537109609079510
Abstract
Human platelets with a high content of endogenous serotonin took up more serotonin when incubated with exogenous serotonin, than platelets with a low endogenous content of serotonin. Also, thrombin-stimulated serotonin secretion (%) was high when endogenous serotonin was high. This was not found with fresh platelets, but was found when platelets were stored as platelet concentrates for 5 and 7 days. With platelets stored for 5 or 7 days, both uptake and secretion were increased after preincubation of the platelets with an amount of exogenous serotonin that was completely taken up. Inhibition of the reuptake of serotonin by imipramine during thrombin-induced secretion increased the secretion in stored platelets. Agonists like collagen, ADP, and a prostaglandin analogue (U46619) gave only 3-7% secretion. Imipramine increased the secretion induced by U46619, but not the secretion induced by ADP or collagen. The specific 5-HT(2) receptor inhibitor, ketanserin, had no effect on agonist stimulated secretion, or secretion stimulated by a calcium ionophore (A23187). Both the uptake and the thrombin-induced secretion of serotonin correlated significantly with endogenous serotonin in stored platelets. In fresh platelets the uptake of serotonin correlated positively, although not significantly, with endogenous serotonin. It is speculated that endogenous serotonin may affect secretion through stimulation of the thrombin receptor, at least in stored platelets.Keywords
This publication has 13 references indexed in Scilit:
- Local Effect of Serotonin Released during Coronary AngioplastyNew England Journal of Medicine, 1994
- The synergistic effect of 5-hydroxytryptamine and epinephrine on the human platelet is related to the activation of phospholipase CEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Serotonin and Acute Ischemic Heart DiseaseNew England Journal of Medicine, 1991
- Vascular Protection by Ketanserin, a 5-HT2Serotonergic Receptor Antagonist?Platelets, 1991
- Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cellsAtherosclerosis, 1990
- Platelet serotonergic mechanisms in ischaemic heart diseaseThrombosis Research, 1990
- In vitro study of vascular endothelial injury by activated platelets and its preventionAtherosclerosis, 1989
- Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pHThrombosis Research, 1985
- Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley ratsLife Sciences, 1983
- Increased uptake of serotonin in platelets from car painters occupationally exposed to mixtures of solvents and organic isocyanates.Scandinavian Journal of Work, Environment & Health, 1983